Mochida Pharmaceutical Co's quarterly market cap
increased
from Sep. 2025 (円112,554 Mil) to Dec. 2025 (円125,316 Mil) but then
declined
from Dec. 2025 (円125,316 Mil) to Mar. 2026 (円122,657 Mil).
Mochida Pharmaceutical Co's annual market cap
declined
from Mar. 2024 (円113,624 Mil) to Mar. 2025 (円112,731 Mil) but then
increased
from Mar. 2025 (円112,731 Mil) to Mar. 2026 (円122,657 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mochida Pharmaceutical Co's Enterprise Value for Today is 円90,871 Mil.
Mochida Pharmaceutical Co (TSE:4534) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mochida Pharmaceutical Co Market Cap Related Terms
Mochida Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mochida Pharmaceutical Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Mochida Pharmaceutical Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mochida Pharmaceutical Co (TSE:4534) has a Market Cap of 円111,928 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mochida Pharmaceutical Co and its competitors. According to the industry distribution chart, Mochida Pharmaceutical Co ranks #331 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 32.4%.
Is Mochida Pharmaceutical Co's Market Cap too high?
Mochida Pharmaceutical Co's current Market Cap is 円111,928 Mil. Based on the distribution chart, Mochida Pharmaceutical Co ranks #331 out of 1023 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Mochida Pharmaceutical Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mochida Pharmaceutical Co ranks #331 out of 1023 companies for Market Cap. This puts Mochida Pharmaceutical Co in the upper half of its industry. The industry median Market Cap is 213.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.88, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mochida Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mochida Pharmaceutical Co's current Market Cap is 円111,928 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co (TSE:4534) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,691.61, compared to a current price of 円3,160.00 — trading 14.4% below its estimated fair value. The current Market Cap is 円111,928 Mil. Mochida Pharmaceutical Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Mochida Pharmaceutical Co (TSE:4534), the current Market Cap is 円111,928 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mochida Pharmaceutical Co (TSE:4534) Overvalued in 2026?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円3,160.00 is trading 14.4% below its estimated GF Value™ of 円3,691.61.
GuruFocus considers Mochida Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4534:
Market Cap: 円111,928 Mil
GF Value™: 円3,691.61 vs. price of 円3,160.00 (14.4% below fair value)
No single metric tells the full story. See the TSE:4534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
72GF Score
Get the complete analysis for TSE:4534
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4534 has been successfully added to your 
